News
2014
-
-
Sysmex Launches the New Automated Hematology Analyzer XN-L series - a Compact Model in the XN Family
- Meets Laboratory Needs in Both Emerging and Advanced Markets -
-
-
Sysmex Establishes New Subsidiary in Australia
- Aiming to Further Increase the Company's Presence in the Asia-Pacific Region -
-
-
Sysmex Launches a New Product in the Cytoscreening Field, the LC-1000 Exfoliative Cell Analyzer
- Aiming to Enhance the Efficiency of Future Cervical Cancer Screening Tests -
-
-
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2015 (PDF：377KB)
-
-
Announcement Regarding Revision of Business Forecasts (PDF：93KB)
-
-
Sysmex Announces Revisions to Dividends from Surplus (Interim) and Year-End Dividend Forecast (PDF：86KB)
-
-
Sysmex Wins Awards in 2014 Local Commendation for Kinki Inventions
-
-
Announcement Regarding Revision of Business Forecasts (PDF：81KB)
-
-
Sysmex Selected by the Securities Analysts Association of Japan for Excellence in Disclosure to Individual Investors for the Third Consecutive Year
-
-
Sysmex Selected for Inclusion in the Asia Pacific Index of the Dow Jones Sustainability Indexes for Third Consecutive Year
-
-
Sysmex to Establish New Japanese Base within IMP on Kobe Port Island to Develop Companion Diagnostics Drugs toward the Realization of Personalized Medicine
-
-
Sysmex Establishes New Measurement Technology that Achieves Even Higher Sensitivity for Its HISCL®-Series Immunochemistry Testing Analyzers
-
-
Sysmex Launches New Automated Blood Coagulation Analyzer Models, the CS-2400/2500
-
-
Sysmex Launches the Automated Immunoassay System HISCL®-800, a Compact Analyzer for Immunochemistry Testing
- Space-saving and High-performance in Response to Increasingly Diverse Needs -
-
-
First Japanese-Made Automated Hematology Analyzer Certified under the 3rd Heritage Program of Legacy Analytical Instruments/Scientific Instruments
-
-
Sysmex Receives MHLW Approval to Manufacture and Market Reagent to Monitor Therapeutic Gains on Chronic Myelogenous Leukemia (CML), Japan's First to Report on the International Scale (IS)
-
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015 (PDF：390KB)
-
-
Sysmex's New Instrument Factory, i-Square, Opens in the City of Kakogawa, Hyogo Prefecture
-
-
Sysmex and Toppan Printing to Collaborate in the Genetic Analysis Testing Industry
-
-
Sysmex Inostics GmbH to Collaborate with Merck KGaA to Develop and Commercialize a Blood-Based RAS Biomarker Test for Patients with Metastatic Colorectal Cancer
-
-
Sysmex Launches LIASAUTO P-FDP Hemostasis Reagent
-Enhanced Reagent Performance Leading to Higher Testing Efficiency and Cost Reductions-
-
-
Consolidated Financial Results for the Year Ended March 31, 2014 (PDF：340KB)
-
-
Sysmex Announces Changes from Financial Results and Year-End Dividend Forecasts for the Fiscal Year Ended March 31, 2014 (PDF：79KB)
-
-
Announcement of Executive Change (PDF：112KB)
-
-
Sysmex to Expand Reagent Factories in Germany and Singapore
- Working to Meet Growing Global Demand -
-
-
Sysmex Establishes New Subsidiary in Colombia
- Enhancing Sales and Support Networks in Emerging Markets -
-
-
Sysmex Reinforces Direct Sales and Support Network in India to Expand Business in Non-Hematology Fields
-
-
Sysmex to Launch the HISCL® TARC Assay Kit for Atopic Dermatitis
- Allows for Automated Testing in Only 17 Minutes -
-
-
Sysmex Receives the Fiscal 2014 Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (Prize for Science and Technology)
-
-
Sysmex to Be Special Sponsor of the Kobe Marathon 2014
- We are pleased to have sponsored this exciting event since its inception in 2011 -
-
-
Sysmex Accredited for ISO/IEC 17025 and ISO/IEC 17043 Calibration Laboratory and Proficiency Testing Provider
- Initiatives toward Further Standardization of Clinical Testing and Quality Improvement -
-
-
Sysmex Enters into Clinical Research, Joint Development and Licensing Agreement with Merck Millipore
-Accelerating the Creation of New Cell Analysis Technologies with a View to Personalized Medicine-
-
-
Announcement of Organizational and Personnel Changes (PDF：133KB)
-
-
Promoting Initiatives to Enhance Clinical Value of the OSNA® Method
- Further Raising Value by Improving Workflow in the Detection of Breast Cancer Lymph Node Metastasis -
-
-
(Correction) Partial Correction to Announcement of Stock Split and Corresponding Revisions to the Articles of Incorporation (PDF：36KB)
-
-
Announcement of Stock Split and Corresponding Revisions to the Articles of Incorporation (PDF：95KB)
-
-
FY2013 Nakatani Award and Research Grant Recipients Announced (PDF：79KB)
-
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2014 (PDF：124KB)
-
-
Sysmex Reinforces Sales and Support Structure in Turkey
- Establishes Local Subsidiary to Expand Business in Growing Market -
-
-
Sysmex Launches New ASTRIM FIT Product for Noninvasive Measurement of Estimated Hemoglobin Levels
- Wide support for condition management, from top athletes to people who attend fitness clubs -
